A hnRNPA2B1 agonist effectively inhibits HBV and SARS-CoV-2 omicron in vivo
Sign Up to like & getrecommendations! Published in 2022 at "Protein & Cell"
DOI: 10.1093/procel/pwac027
Abstract: Abstract The twenty-first century has already recorded more than ten major epidemics or pandemics of viral disease, including the devastating COVID-19. Novel effective antivirals with broad-spectrum coverage are urgently needed. Herein, we reported a novel… read more here.
Keywords: inhibits hbv; hnrnpa2b1 agonist; cov omicron; effectively inhibits ... See more keywords